West Pharmaceutical Services has appointed Eric Resnick as vice president and chief technology officer, succeeding John Paproski, who plans to retire on April 1, 2016. Mr. Resnick will be responsible for leading the company’s innovation and technology team, which has been established to create the next generation of products, from innovation to the commercial stage, across the packaging, containment and delivery product areas.

“John Paproski will retire from West with more than 36 years of dedicated service and a legacy of innovative products and services he helped to create and deliver to customers and, ultimately, to patients around the world,” said Eric Green, president and chief executive officer, West. “A consummate leader and trusted colleague, we celebrate John’s contributions to West and his lasting impact, and wish him well in his retirement.”

“I leave West with the knowledge that the company is embarking on a growth journey I have been thrilled to be a part of, and with pride as Eric Resnick, who has served as a critical leader on my team, takes over the reins as chief technology officer,” said Mr. Paproski. “I have enjoyed my time at West immensely and look forward to watching the company continue to grow and evolve as I pursue retirement.”

“Over the past 15 years, Eric Resnick has been a pivotal leader within West. His work to bring the SmartDose electronic wearable injector from concept to commercialization is among many of his accomplishments,” said Mr. Green. “Eric is a well-respected and proven leader at West who will bring valuable skills and experience to the West leadership team. I am confident he will further the great work that has been done to bring innovative, new products to market.”

Mr. Resnick most recently served as vice president and general manager of integrated packaging and delivery within the innovation and technology team.